BRIEF-Cytokinetics announces first patient enrolled in VIGOR-ALS
October 18, 2016 at 07:49 AM EDT
* Cytokinetics announces first patient enrolled in VIGOR-ALS, an open-label extension clinical trial of tirasemtiv Source text for Eikon: Further company coverage:
